The most important feature of the Koç University Hospital Clinical Trials Unit (CTU) is that it provides volunteers with quality healthcare services and improves their access to new treatment methods and drugs in a safe environment. Our research and development efforts, particularly focused on combating cancer, not only contribute to science but also offer hope to patients. Innovative drug and medical device research, some of which are first-in-human, provides our volunteers valuable access to new treatments. Our Unit provides a workspace for physician-scientists and nurses in the field of clinical research. With its “Phase 1 Clinical Research Center,” the CTU is one of the few exemplary clinical research centers in Türkiye and neighboring countries. In our center, Phase 1-2-3 drug studies and medical device studies are conducted.
The Unit has 7 patient beds in the Phase 1 Center, 4 outpatient examination rooms and its own pharmacy and laboratory. The Unit currently runs 30+ clinical trials in partnership with global pharmaceutical and medical device companies as well as distinguished academic centers including Oxford University and Mayo Clinic.
Thanks to our strategic collaborations with BioNTech and other partners, as well as the quality healthcare services of Koç University Hospital, we bring innovative medical technologies such as mRNA-based cancer vaccines, immunotherapies, and cell therapies to patients in Türkiye.
Our Unit is fully licensed by the Turkish Medicines and Medical Devices Agency and partners with Mayo Clinic to improve the quality of clinical trials.
To learn more about our ongoing studies, you can review the list on this page and contact our respective physician. For inquiries, please contact us at ctu@kuh.ku.edu.tr or call Koç University Hospital Call Center: +90 (850) 250 82 50